AngioDynamics, Inc. (ANGO) Operating cash flow 2017–2026
AngioDynamics, Inc. (ANGO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$3.1MFY2026 · since FY2017: $55.7M → $3.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $3.1M | +130.5% |
| FY2025 | -$10.1M | +64.0% |
| FY2024 | -$28.2M | -36200.0% |
| FY2023 | $78,000 | +101.1% |
| FY2022 | -$7.2M | -129.9% |
| FY2021 | $24.1M | +265.5% |
| FY2020 | -$14.6M | -138.9% |
| FY2019 | $37.4M | -9.3% |
| FY2018 | $41.3M | -25.9% |
| FY2017 | $55.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice